S.VargheseL.GeethaK
The dosage of phentermine requires reduction in people with severe kidney impairment and it should be avoided in people with end-stage kidney disease
Importantly, neutralization of DBI did not affect nausea-like behavior (measured by kaolin intake), and only slightly blunted weight loss, indicating that DBI is specifically tied to appetite suppression rather than side effects
10.1038/s41598-017-15809-4 13
specializing in weight management, GLP-1 medication nutrition therapy, bariatric surgery, digestive health, and sustainable behavior change Leah Jones, MD Board-certified in Internal Medicine and Obesity Medicine Katherine Austin, MD, MPH, FAAP, FRCP(C) Board-certified in Pediatrics and Adolescent Medicine Heather Cecchini, MSN, APRN, ANP-C Board-certified Adult-Primary Care Nurse Practitioner Clete Barrick, MD Board-certified in Internal Medicine and Obesity Medicine Caitlin Camill, RDN, CDCES Certified Diabetes Care and Education Specialist